Trials / Completed
CompletedNCT07489183
A Prospective, Open, Observational Study to Confirm the Lipid-lowering Effect, Changes in Glucose Metabolism, and Safety After 6 Months of Administration of Atostazet to Hypercholesterolemic Patients 65 Years of Age or Older
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 641 (actual)
- Sponsor
- Dong Wha Pharmaceutical Co. Ltd. · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, open, observational study to confirm the lipid-lowering effect, changes in glucose metabolism, and safety after 6 months of administration of atostazet to hypercholesterolemic patients 65 years of age or older
Conditions
Timeline
- Start date
- 2021-08-23
- Primary completion
- 2023-09-07
- Completion
- 2023-09-07
- First posted
- 2026-03-24
- Last updated
- 2026-03-24
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07489183. Inclusion in this directory is not an endorsement.